Cue
Also: Amwell misses revenue expectations and Babylon Health grows 371% year-over-year. 
        
        
          Cue received emergency use authorization for its at-home COVID-19 test in March and went public in September.
        
        
          Also Cue Health scores $13 million from the department of Health and Human Services Biomedical Advanced Research and Development authority in order to fund its portable COVID-19 diagnostic test.
        
        
           
